Capital BioVentures
Overview
Capital BioVentures is a not-for-profit wet-lab accelerator and incubator firm that supports early-stage biotech and life science companies in Canada.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NuvoBio | Dec 2024 | Grant | Lead |
| Cura Therapeutics | Nov 2025 | Accelerator | Lead |
| Yellowbird Diagnostics Inc. | Dec 2024 | Accelerator | Co-investor |
| Rhythm Biotherapeutics | Nov 2024 | Grant | Lead |
| Virano Therapeutics | Dec 2024 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Capital BioVentures based?
Capital BioVentures is headquartered in Ottawa, Canada.
When was Capital BioVentures founded?
Capital BioVentures was founded in 2023.
How many portfolio companies does Capital BioVentures have?
Capital BioVentures has 5 portfolio companies in Caplight's dataset.
What are some companies in Capital BioVentures's portfolio?
Portfolio companies visible on Caplight include NuvoBio, Cura Therapeutics, Yellowbird Diagnostics Inc., Rhythm Biotherapeutics, Virano Therapeutics.
What was Capital BioVentures's most recent investment shown here?
Capital BioVentures's most recent investment in this portfolio sample was in Cura Therapeutics in 2025.
What sectors does Capital BioVentures focus on?
Capital BioVentures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Capital BioVentures focus on?
Stage focus information for Capital BioVentures is not publicly available.